Financial Enhancement Group LLC Pfizer Inc Transaction History

Financial Enhancement Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $2,713 - $3,312	-62 Reduced 4.35%	1,363 $60,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $325 - $386	-7 Reduced 0.49%	1,425 $75,000
Q1 2022 May 18, 2022	SELL	$45.75 - $56.69 $2,196 - $2,721	-48 Reduced 3.24%	1,432 $74,000
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $8,801 - $13,046	213 Added 16.81%	1,480 $87,000
Q3 2021 Oct 14, 2021	SELL	$39.25 - $50.42 $628 - $806	-16 Reduced 1.25%	1,267 $54,000
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $2,210 - $2,492	-66 Reduced 4.89%	1,283 $46,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $40,130 - $51,029	1,199 Added 799.33%	1,349 $50,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $33,734 - $40,924	-1,120 Reduced 88.19%	150 $5,000
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $42,000 - $46,144	1,120 Added 746.67%	1,270 $54,000
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $4,786 - $5,553	150 New	150 $5,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Enhancement Group LLC with notifications on news.